Search
JZP269
go.drugbank.com/drugs/DB33939ExperimentalJZP269 is under investigation in clinical trial NCT07813663 (A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of JZP269 in Healthy Male and Female Participants).
Apocynin
go.drugbank.com/drugs/DB12618InvestigationalAcetovanillone has been used in trials studying the treatment of Bronchial Asthma and Chronic Obstructive Pulmonary Disease.
Categories: Analgesics, Non-NarcoticRosmarinic acid
go.drugbank.com/drugs/DB16865InvestigationalCategories: Analgesics, Non-Narcotic, Anti-Inflammatory Agents, Non-SteroidalPamiparib
go.drugbank.com/drugs/DB14769InvestigationalPamiparib is under investigation in clinical trial NCT03933761 (Pamiparib in Fusion Positive, Reversion Negative High Grade Serous Ovarian Cancer or Carcinosarcoma With BRCA1/2 Gene Mutations If Progression on
Muplestim
go.drugbank.com/drugs/DB12431InvestigationalMuplestim is under investigation in clinical trial NCT00002258 (A Phase I, Open Label Trial to Evaluate the Safety, Tolerance and Biological Effects of SDZ ILE-964 (Recombinant Human Interleukin-3, RhIL
Synonyms: IL-3 (NON-GLYCOSYLATED)BMN-351
go.drugbank.com/drugs/DB18186InvestigationalBMN-351 is a fully modified 18-mer oligonucleotide with a TEG modification at its 5' end that binds to exon 51 of dystrophin pre-mRNA.
Azemiglitazone
go.drugbank.com/drugs/DB16028InvestigationalAzemiglitazone is under investigation in clinical trial NCT01280695 (A Randomized, Double-blind, Comparator- and Placebo-controlled, Multiple-dose Study to Evaluate the Safety, Tolerability and Efficacy
Insulin efsitora alfa
go.drugbank.com/drugs/DB19013InvestigationalInsulin efsitora alfa is under investigation in clinical trial NCT05662332 (A Study of Insulin Efsitora Alfa (LY3209590) Compared to Glargine in Adult Participants With Type 2 Diabetes Who Are Starting
Zosurabalpin
go.drugbank.com/drugs/DB21539InvestigationalZosurabalpin is under investigation in clinical trial NCT05614895 (A Study to Investigate the Pharmacokinetics of RO7223280 in Critically Ill Participants With Bacterial Infections).